ATTeST
April 9, 2023
ATTeST Completed Clinical Studies & Trials
Location:
Global, multi-site
Investigator:
EryDel, S.p.A.
Purpose:
This large placebo controlled, cross-over trial assessed the safety and efficacy of the EryDex System (dexamethasone sodium phosphate loaded red blood cells) to treat neurological symptoms associated with A-T. For more information, please visit the ATTeST website.
Conclusions
Data analysis ongoing.